The Stamp of Approval supports the inclusion of high-quality, natural sugars, allowing consumers to recognize the added value in terms of health and performance.
To help make these healthier sugars more accessible, Dr Johannes Coy established the Dr Coy Stamp of Approval. This stamp not only represents the scientifically supported benefits but also confirms Dr. Coy’s scientific credibility and research.
The Stamp of Approval allows food and beverage manufacturers to clearly convey the health benefits and scientific importance of these sugars.
Here's Why:
Dr. Coy is the discoverer of the TKTL1 gene and its sugar metabolism pathway, the TKTL1 Fermentation Pathway. This pathway generates essential building blocks for new cell formation and cellular repair such as ribose and acetyl-CoA. .
2022 Nobel Prize winner Svante Pääbo and colleagues from the Max Planck Society proved that the replacement of a single amino acid in the TKTL1 protein of modern humans, compared to the TKTL1 protein of Neanderthals, has altered the gene in such a way that significantly more nerve cells are formed in the brain (neocortex). Also, the folding of the cerebral cortex is stronger, creating more space for the increased number of nerve cells.
This specific change in enzymatic properties caused the TKTL1 gene to be incredibly important for the increased cognitive performance of modern humans. Over time this gene has become a major factory within our body, in charge of creating new DNA, cells, and managing our metabolism.
This groundbreaking discovery has solidified Dr Coy’s reputation as a leading pioneer in biochemistry and medicine. His work with the TKTL1 Fermentation Pathway has revealed the intrinsic link between TKTL1 and the rise in modern lifestyle diseases such as diabetes, Alzheimer’s, and cancer. Recognizing the link between sugar and disease, Dr Coy formulated unique mixtures of natural, healthy sugars designed to optimise physical and mental health.
He dedicated over three decades of research to uncover how these sugars can adapt to each individual’s unique needs and enable targeted activation of the TKTL1 sugar metabolism to support disease prevention.